HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stada Plots Eastern European Expansion With Walmark Deal

Executive Summary

Stada is set to snap up Czech Republic-based Walmark in its second major deal this year as it looks to make good on its promise to rapidly expand its OTC-focused Branded Products business. 

You may also be interested in...



People On The Move: Appointments At Stada, Bayer and Anses

Stada hires Accord's Romaniszyn to lead its business in Poland; Bayer extends the contract of chairman Werner Baumann; and France's Anses appoints a new chair of the board.

Stada Hints At Further Deals To Come As It Posts Big Sales Rise

Germany's Stada posts 22% jump in first half sales thanks to recent deals and reveals that more acquisitions may soon follow.

Stada's Nature’s Aid Submits CBD Novel Food Application

HBW Insight speaks exclusively to Chris Morrey, CEO of Stada's UK Nature's Aid subsidiary, about the company's experiments with CBD and its recently submitted EU novel food application. 

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT142464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel